Adenosine A1 receptor

Adenosine A1 receptor is a type of adenosine receptor that has a high affinity for adenosine, a molecule found throughout the body that has various physiological effects. The A1 receptor is a G protein-coupled receptor (GPCR) involved in a wide range of cellular functions, including inhibition of adenylate cyclase, modulation of potassium channels, and regulation of neurotransmitter release.

Function

The adenosine A1 receptor plays a crucial role in the cardiovascular system, where it helps to regulate myocardial oxygen demand and coronary blood flow. Activation of this receptor in the heart leads to decreased heart rate (bradycardia), reduced cardiac contractility, and increased coronary vasodilation, which are protective mechanisms during ischemic conditions. In the central nervous system, the A1 receptor contributes to the sedative, anticonvulsant, and neuroprotective effects of adenosine. It is also involved in the modulation of sleep and wakefulness cycles.

Distribution

Adenosine A1 receptors are widely distributed throughout the body, with high concentrations found in the brain, particularly in areas involved in regulating sleep, such as the thalamus and basal forebrain. They are also present in the heart, kidneys, and adipose tissue.

Mechanism of Action

Upon binding of adenosine, the A1 receptor activates an inhibitory G protein (Gi protein), which in turn inhibits adenylate cyclase activity. This leads to a decrease in cyclic AMP (cAMP) levels and subsequent modulation of other signaling pathways. In neurons, this can result in hyperpolarization and reduced neurotransmitter release. In the heart, it leads to the effects described above, contributing to the protective role of adenosine during oxygen deprivation.

Clinical Significance

The adenosine A1 receptor is a target for several therapeutic applications. Agonists of this receptor can be used to treat conditions such as supraventricular tachycardia, a type of fast heart rate. They are also being explored for their potential in protecting the heart from ischemic damage during heart attacks. Conversely, antagonists of the A1 receptor may improve wakefulness and have applications in treating disorders such as narcolepsy and obstructive sleep apnea.

Pharmacology

Several synthetic agonists and antagonists of the adenosine A1 receptor have been developed for clinical and research purposes. These compounds vary in their specificity and affinity for the A1 receptor, influencing their therapeutic applications and side effects.

See Also

• Adenosine
• G protein-coupled receptor
• Adenosine A2A receptor
• Adenosine A2B receptor
• Adenosine A3 receptor

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian